MedTrace Logo

Angelman Syndrome Natural History Study

NCT04507997 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-04-03

No results posted yet for this study

Summary

The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.

Conditions

Sponsors & Collaborators

  • University of California, San Diego

    collaborator OTHER

  • Angelman Syndrome Biomarker & Outcome Measure Consortium (A-BOM)

    collaborator UNKNOWN

  • Food and Drug Administration (FDA)

    collaborator FED

  • Angelman Syndrome Foundation Canada

    collaborator UNKNOWN

  • Foundation for Angelman Syndrome Therapeutics Canada

    collaborator UNKNOWN

  • Foundation for Angelman Syndrome Therapeutics

    collaborator UNKNOWN

  • Angelman Syndrome Foundation, Inc.

    collaborator OTHER

  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • Wen-Hann Tan, BMBS · Boston Children's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2031-04-30
Completion
2031-04-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04507997 on ClinicalTrials.gov